We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$37M
1-Year Est. Return
63.54%
This Fund
S&P 500
This Quarter
Est. Return
-6.42%
1 Year Est. Return
+63.54%
3 Year Est. Return
+38.32%
5 Year Est. Return
+47.02%
10 Year Est. Return
+2,089.98%
AUM
$3.29B
AUM Growth
+$73M
(+2.3%)
Cap. Flow
+$288M
Cap. Flow
% of AUM
8.77%
Top 10 Holdings %
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivaNova
LIVN
|
+$42.5M |
| 2 |
MAPS
WM TECHNOLOGY INC A
MAPS
|
+$23.3M |
| 3 |
Seer Inc
SEER
|
+$20.8M |
| 4 |
Glaukos
GKOS
|
+$17.9M |
| 5 |
Cooper Companies
COO
|
+$17.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$60.7M |
| 2 |
Intellia Therapeutics
NTLA
|
+$26.2M |
| 3 |
Organogenesis Holdings
ORGO
|
+$19.9M |
| 4 |
Eli Lilly
LLY
|
+$15.1M |
| 5 |
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.25% |
| 2 | Consumer Staples | 0.8% |
| 3 | Technology | 0.71% |
| 4 | Industrials | 0.71% |
| 5 | Materials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Quanterix
QTRX
$136M
| $16.3M | 0.5% |
326,712
+20,245
| +7% | +$1.04M |
|
52
Hydrofarm Holdings
HYFM
$8.05M
| $16.2M | 0.49% |
42,729
+3,952
| +10% | +$1.92M |
|
|
CANO
53
DELISTED
Cano Health, Inc.
CANO
| $16.2M | 0.49% |
+12,750
| New | +$15.5M |
|
54
CALL
Medtronic
MDT
$116B
| $15M | 0.46% |
+120,000
| New | +$15.5M |
|
|
NUVA
55
PUT
DELISTED
NuVasive, Inc.
NUVA
| $15M | 0.46% |
+250,000
| New | +$15.4M |
|
56
DexCom
DXCM
$34.4B
| $14.8M | 0.45% |
108,408
+3,132
| +3% | +$395K |
|
|
HOLX
57
PUT
DELISTED
Hologic
HOLX
| $14.8M | 0.45% |
200,000
+125,000
| +167% | +$9.37M |
|
|
OLPX
58
DELISTED
Olaplex Holdings
OLPX
| $14.7M | 0.45% |
+600,000
| New | +$14.7M |
|
59
PUT
Trupanion
TRUP
$1.35B
| $14.6M | 0.44% |
188,200
+163,200
| +653% | +$16.1M |
|
60
PUT
Veeva Systems
VEEV
$40.6B
| $14.4M | 0.44% |
+50,000
| New | +$15.9M |
|
61
PUT
Mettler-Toledo International
MTD
$28.7B
| $13.8M | 0.42% |
+10,000
| New | +$15.1M |
|
|
QTNT
62
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $13.7M | 0.42% |
146,495
+34,852
| +31% | +$4.35M |
|
|
APR
63
DELISTED
Apria, Inc. Common Stock
APR
| $13.2M | 0.4% |
355,465
-344,255
| -49% | -$11.3M |
|
|
SLGC
64
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $12.9M | 0.39% |
+1,037,645
| New | +$11.7M |
|
|
65
CALL
Intellia Therapeutics
NTLA
$1.66B
| $12.8M | 0.39% |
95,700
-206,700
| -68% | -$31.3M |
|
66
PUT
CVS Health
CVS
$121B
| $12.7M | 0.39% |
+150,000
| New | +$12.6M |
|
67
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.28B
| $12.6M | 0.38% |
+100,000
| New | +$16M |
|
|
68
CALL
Glaukos
GKOS
$11.1B
| $12M | 0.37% |
+250,000
| New | +$13.9M |
|
|
CNVY
69
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $12M | 0.37% |
+1,429,946
| New | +$12.7M |
|
70
CALL
Bausch Health
BHC
$2.34B
| $12M | 0.36% |
+430,000
| New | +$12.2M |
|
71
PUT
Tandem Diabetes Care
TNDM
$1.61B
| $11.9M | 0.36% |
+100,000
| New | +$11M |
|
72
Apyx Medical
APYX
$126M
| $11.9M | 0.36% |
857,018
-95,027
| -10% | -$1,000K |
|
73
PUT
Abbott
ABT
$192B
| $11.8M | 0.36% |
+100,000
| New | +$12.3M |
|
74
Agilon Health
AGL
$1.5B
| $11.7M | 0.36% |
17,896
+2,538
| +17% | +$2.17M |
|
75
PUT
Zoetis
ZTS
$31B
| $11.6M | 0.35% |
60,000
+10,000
| +20% | +$2.02M |
|
Similar funds
CI
RH
ICP
GC
BAM
CM
AP
ACM
Pura Vida Investments's Q3 2021 Portfolio in Review
As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.
- Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
- Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
- Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
- Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
- Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
- Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
- Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.
Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.